tiprankstipranks
Trending News
More News >
Silexion Therapeutics Corp (SLXN)
:SLXN
US Market

Silexion Therapeutics (SLXN) Balance Sheet

Compare
212 Followers

Silexion Therapeutics Balance Sheet

Silexion Therapeutics's total assets for Q3 2025 were $11.61M, an increase of 100.35% from the previous quarter. SLXN total liabilities were $4.64M for the fiscal quarter, a -18.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 2.86M$ 5.26M$ 9.33M$ 115.41M$ 129.40K
Total Liabilities
$ 6.85M$ 17.31M$ 16.41M$ 508.92K$ 299.39K
Total Equity Gross Minority
$ -3.99M$ -12.06M$ -7.08M$ 114.91M$ -169.99K
Other Metrics
Currency in USD

Silexion Therapeutics Debt to Assets